How much profit has Cipla made this year?
Cipla has made 41.22 B INR this year.
Cipla Net Income 2024
Cipla Net Income
41.22 B INR
Ticker
CIPLA.NS
ISIN
INE059A01026
In 2024, Cipla's profit amounted to 41.22 B INR, a 47.1% increase from the 28.02 B INR profit recorded in the previous year.
The Cipla Net Income history
| YEAR | NET INCOME (undefined INR) |
|---|---|
| 2027e | 54.46 |
| 2026e | 53.77 |
| 2025e | 47.92 |
| 2024 | 41.22 |
| 2023 | 28.02 |
| 2022 | 25.17 |
| 2021 | 24.05 |
| 2020 | 15.47 |
| 2019 | 15.28 |
| 2018 | 14.11 |
| 2017 | 10.06 |
| 2016 | 13.6 |
| 2015 | 11.81 |
| 2014 | 13.88 |
| 2013 | 15.45 |
| 2012 | 11.44 |
| 2011 | 9.9 |
| 2010 | 10.83 |
| 2009 | 7.71 |
| 2008 | 7.01 |
| 2007 | 6.68 |
| 2006 | 6.08 |
| 2005 | 4.1 |
Cipla Revenue, EBIT, Net Income INE059A01026 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Cipla, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cipla from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cipla’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Cipla. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Cipla’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Cipla’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cipla’s growth potential.
Cipla Revenue, EBIT and net profit per share
| Date | Cipla Revenue | Cipla EBIT | Cipla Net Income |
|---|---|---|---|
| 2027e | 334.41 B INR | 67.74 B INR | 54.46 B INR |
| 2026e | 316.15 B INR | 68.53 B INR | 53.77 B INR |
| 2025e | 286.81 B INR | 61.68 B INR | 47.92 B INR |
| 2024 | 257.74 B INR | 53.65 B INR | 41.22 B INR |
| 2023 | 227.53 B INR | 40.17 B INR | 28.02 B INR |
| 2022 | 217.63 B INR | 35.76 B INR | 25.17 B INR |
| 2021 | 191.6 B INR | 32.67 B INR | 24.05 B INR |
| 2020 | 171.32 B INR | 21.18 B INR | 15.47 B INR |
| 2019 | 163.62 B INR | 20.08 B INR | 15.28 B INR |
| 2018 | 152.19 B INR | 18.83 B INR | 14.11 B INR |
| 2017 | 146.3 B INR | 16.63 B INR | 10.06 B INR |
| 2016 | 137.9 B INR | 17.28 B INR | 13.6 B INR |
| 2015 | 113.45 B INR | 16.59 B INR | 11.81 B INR |
| 2014 | 101.73 B INR | 17.77 B INR | 13.88 B INR |
| 2013 | 82.79 B INR | 18.87 B INR | 15.45 B INR |
| 2012 | 70.21 B INR | 13.84 B INR | 11.44 B INR |
| 2011 | 63.24 B INR | 11.01 B INR | 9.9 B INR |
| 2010 | 53.6 B INR | 9.62 B INR | 10.83 B INR |
| 2009 | 49.61 B INR | 8.1 B INR | 7.71 B INR |
| 2008 | 40.1 B INR | 5.1 B INR | 7.01 B INR |
| 2007 | 34.38 B INR | 5.84 B INR | 6.68 B INR |
| 2006 | 28.91 B INR | 5.33 B INR | 6.08 B INR |
| 2005 | 21.81 B INR | 3.67 B INR | 4.1 B INR |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 21.81 B INR | 3.67 B INR | 4.1 B INR |
| 2006 | 28.91 B INR | 5.33 B INR | 6.08 B INR |
| 2007 | 34.38 B INR | 5.84 B INR | 6.68 B INR |
| 2008 | 40.1 B INR | 5.1 B INR | 7.01 B INR |
| 2009 | 49.61 B INR | 8.1 B INR | 7.71 B INR |
| 2010 | 53.6 B INR | 9.62 B INR | 10.83 B INR |
| 2011 | 63.24 B INR | 11.01 B INR | 9.9 B INR |
| 2012 | 70.21 B INR | 13.84 B INR | 11.44 B INR |
| 2013 | 82.79 B INR | 18.87 B INR | 15.45 B INR |
| 2014 | 101.73 B INR | 17.77 B INR | 13.88 B INR |
| 2015 | 113.45 B INR | 16.59 B INR | 11.81 B INR |
| 2016 | 137.9 B INR | 17.28 B INR | 13.6 B INR |
| 2017 | 146.3 B INR | 16.63 B INR | 10.06 B INR |
| 2018 | 152.19 B INR | 18.83 B INR | 14.11 B INR |
| 2019 | 163.62 B INR | 20.08 B INR | 15.28 B INR |
| 2020 | 171.32 B INR | 21.18 B INR | 15.47 B INR |
| 2021 | 191.6 B INR | 32.67 B INR | 24.05 B INR |
| 2022 | 217.63 B INR | 35.76 B INR | 25.17 B INR |
| 2023 | 227.53 B INR | 40.17 B INR | 28.02 B INR |
| 2024 | 257.74 B INR | 53.65 B INR | 41.22 B INR |
| 2025e | 286.81 B INR | 61.68 B INR | 47.92 B INR |
| 2026e | 316.15 B INR | 68.53 B INR | 53.77 B INR |
| 2027e | 334.41 B INR | 67.74 B INR | 54.46 B INR |
Cipla stock margins INE059A01026 ·
The Cipla margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cipla. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cipla.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Cipla's sales revenue. A higher gross margin percentage indicates that the Cipla retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Cipla's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Cipla's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cipla's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cipla. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cipla's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Cipla Margin History
| Cipla Gross margin | Cipla Profit margin | Cipla EBIT margin | Cipla Profit margin |
|---|---|---|---|
| 2027e | 61.37 % | 20.26 % | 16.28 % |
| 2026e | 61.37 % | 21.68 % | 17.01 % |
| 2025e | 61.37 % | 21.5 % | 16.71 % |
| 2024 | 61.37 % | 20.82 % | 15.99 % |
| 2023 | 59.06 % | 17.65 % | 12.31 % |
| 2022 | 56.07 % | 16.43 % | 11.56 % |
| 2021 | 56.53 % | 17.05 % | 12.55 % |
| 2020 | 59.51 % | 12.36 % | 9.03 % |
| 2019 | 59.08 % | 12.27 % | 9.34 % |
| 2018 | 57.84 % | 12.37 % | 9.27 % |
| 2017 | 56.4 % | 11.37 % | 6.88 % |
| 2016 | 56.27 % | 12.53 % | 9.86 % |
| 2015 | 57.6 % | 14.62 % | 10.41 % |
| 2014 | 56.43 % | 17.47 % | 13.65 % |
| 2013 | 57.74 % | 22.79 % | 18.66 % |
| 2012 | 53.43 % | 19.71 % | 16.3 % |
| 2011 | 47.44 % | 17.41 % | 15.65 % |
| 2010 | 50.16 % | 17.95 % | 20.2 % |
| 2009 | 45.29 % | 16.32 % | 15.54 % |
| 2008 | 43.93 % | 12.72 % | 17.48 % |
| 2007 | 44.77 % | 16.99 % | 19.42 % |
| 2006 | 45.66 % | 18.43 % | 21.01 % |
| 2005 | 43.84 % | 16.82 % | 18.78 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 43.84 % | 16.82 % | 18.78 % |
| 2006 | 45.66 % | 18.43 % | 21.01 % |
| 2007 | 44.77 % | 16.99 % | 19.42 % |
| 2008 | 43.93 % | 12.72 % | 17.48 % |
| 2009 | 45.29 % | 16.32 % | 15.54 % |
| 2010 | 50.16 % | 17.95 % | 20.2 % |
| 2011 | 47.44 % | 17.41 % | 15.65 % |
| 2012 | 53.43 % | 19.71 % | 16.3 % |
| 2013 | 57.74 % | 22.79 % | 18.66 % |
| 2014 | 56.43 % | 17.47 % | 13.65 % |
| 2015 | 57.6 % | 14.62 % | 10.41 % |
| 2016 | 56.27 % | 12.53 % | 9.86 % |
| 2017 | 56.4 % | 11.37 % | 6.88 % |
| 2018 | 57.84 % | 12.37 % | 9.27 % |
| 2019 | 59.08 % | 12.27 % | 9.34 % |
| 2020 | 59.51 % | 12.36 % | 9.03 % |
| 2021 | 56.53 % | 17.05 % | 12.55 % |
| 2022 | 56.07 % | 16.43 % | 11.56 % |
| 2023 | 59.06 % | 17.65 % | 12.31 % |
| 2024 | 61.37 % | 20.82 % | 15.99 % |
| 2025e | 61.37 % | 21.5 % | 16.71 % |
| 2026e | 61.37 % | 21.68 % | 17.01 % |
| 2027e | 61.37 % | 20.26 % | 16.28 % |
Cipla Aktienanalyse
What does Cipla do?
Cipla Ltd is an Indian pharmaceutical company based in Mumbai. The company was founded in 1935 and is now one of the largest producers of generics worldwide. The name "Cipla" is an abbreviation for "Chemical, Industrial & Pharmaceutical Laboratories". Business Model: Cipla specializes in the production of high-quality generics. This means that they manufacture medication that has the same active ingredients as the original drugs. This allows them to offer medication at a significantly lower price. However, Cipla not only offers generics but also develops its own innovative medication. The focus is on therapy areas such as oncology, respiratory diseases, HIV/AIDS, diabetes, and cardiovascular diseases. Divisions: Cipla is divided into several divisions, including generics, specialty drugs, and biologics. The generics division is the company's core competence. Here, Cipla produces a variety of medications in different forms, such as tablets, capsules, suspensions, etc. The specialty drugs division focuses on innovative medications that are usually more expensive than generics. This includes medications for the treatment of cancer or autoimmune diseases. In the biologics division, Cipla produces biotechnology products based on the use of living cells. Products: Cipla offers a wide range of products, including medications for asthma, diabetes, hypertension, and infectious diseases. Some of the most well-known medications are Escitalopram (an antidepressant), Seroflo (an asthma medication), Tenofovir (an HIV medication), and Sorafenib (a cancer medication). The company continuously works on new products and invests heavily in research and development. Cipla also has a social responsibility. The company is involved in the fight against HIV/AIDS and produces life-saving medication for this disease at an affordable price. Furthermore, Cipla has launched a program called "Cipla Foundation" which works towards improving healthcare in developing countries. Overall, Cipla has achieved impressive growth and is now one of the most significant pharmaceutical companies worldwide. The company has proven that it is possible to offer high-quality medication at an affordable price and still be successful. Cipla ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Cipla's Profit Margins
The profit margins of Cipla represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Cipla's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Cipla's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Cipla's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Cipla’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Cipla stock
How has the profit developed compared to last year?
The profit has increased by 47.1% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Cipla publish its earnings?
Cipla publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Cipla?
The profits of Cipla are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Cipla?
You can learn more about the earnings of Cipla by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Cipla pay?
Over the past 12 months, Cipla paid a dividend of 13 INR . This corresponds to a dividend yield of about 0.79 %. For the coming 12 months, Cipla is expected to pay a dividend of 14.32 INR.
What is the dividend yield of Cipla?
The current dividend yield of Cipla is 0.79 %.
When does Cipla pay dividends?
Cipla pays a quarterly dividend. This is distributed in the months of September, September, August, September.
How secure is the dividend of Cipla?
Cipla paid dividends every year for the past 23 years.
What is the dividend of Cipla?
For the upcoming 12 months, dividends amounting to 14.32 INR are expected. This corresponds to a dividend yield of 0.87 %.
In which sector is Cipla located?
Cipla is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cipla kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cipla from 9/19/2024 amounting to 13 INR, you needed to have the stock in your portfolio before the ex-date on 8/2/2024.
When did Cipla pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Cipla in the year 2023?
In the year 2023, Cipla distributed 8.5 INR as dividends.
In which currency does Cipla pay out the dividend?
The dividends of Cipla are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cipla
Our stock analysis for Cipla Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cipla Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.